SRP118913 PRJNA412231 GSE104269 Modulation of synaptic phosphodiesterase PDE2A activity is a new therapeutic approach for Fragile X Syndrome in newborns and adolescents. FMR1 HITS-CLIP experiments of mice cerebellum, cortex and Hypocamppi Overall design: 2 replicate for cerebellum, 4 for cortex and 5 for hippocamppus region of mice brain. GSE104269 pubmed 29668986